0001209191-20-050028.txt : 20200910
0001209191-20-050028.hdr.sgml : 20200910
20200910180553
ACCESSION NUMBER: 0001209191-20-050028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200910
DATE AS OF CHANGE: 20200910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WILSON TROY EDWARD
CENTRAL INDEX KEY: 0001589597
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 201169463
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 3033 SCIENCE PARK RD, SUITE 220
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-08
0
0001422143
Kura Oncology, Inc.
KURA
0001589597
WILSON TROY EDWARD
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
1
1
0
0
President and CEO
Common Stock
2020-09-08
4
S
0
50000
26.00
D
306736
I
by Araxes Pharma LLC
Common Stock
2020-09-10
4
S
0
1025
28.00
D
305711
I
by Araxes Pharma LLC
Common Stock
2020-09-10
4
M
0
37030
6.15
A
65126
D
Common Stock
2020-09-10
4
S
0
37030
28.00
D
28096
D
Common Stock
1795017
I
by Red Fish Blue Fish Revocable Trust
Option to purchase common stock
6.15
2020-09-10
4
M
0
37030
0.00
D
2027-01-22
Common Stock
37030
174947
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2019 and amended on June 8, 2020.
The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019 and amended on December 23, 2019 and June 8, 2020.
This option vests in 48 equal monthly installments commencing on January 23, 2017.
James Basta, Attorney-in-fact for Troy E. Wilson
2020-09-10